Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global and China Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

  • QYR603824
  • 180 Pages
  • June 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
The global Drugs for Treatment of Prostate Cancer market was valued at USD 43.47 Billion in 2015, and is projected to reach USD 52.16 Billion by 2021, at a CAGR of 9.99% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Prostate Cancer in Global market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China, forecast to 2021, from 2015.And Zytiga took up 51.33% market share in 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.

With 180 pages, 216 charts and eight chapters, to display the market present situation and future, clearly and deeply.

Table of Contents

Global and China Drugs for Treatment of Prostate Cancer Research Report to 2021

1 Drugs for Treatment of Prostate Cancer Overview and Each Type

1.1 Product Overview of Prostate Cancer

1.1.1 Definition and Product Scope of Drugs for Prostate Cancer

1.1.2 Global Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021

1.13 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021

1.2 Product Segments and Price of Each Type

1.2.1 Product Type of Key Manufacturers

1.2.2 Price List and of Each Type 2015 to 2016

1.2.3 Market Share and Growth Rate of Each Type

1.2.4 Triptorelin and Specification

1.2.5 Leuprorelin and Specification

1.2.6 Flutamide Tablets and Specification

1.2.7 Goserelin and Specification

1.2.8 Bicalutamide Tablets and Specification

1.2.9 Bicalutamide Capsules and Specification

1.2.10 Estramustine Phosphate Capsules and Specification

1.2.11 Mitoxantrone and Specification

1.2.12 Zytiga and Specification

1.2.13 Xtandi and Specification

1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016

1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers

1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers

1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers

1.3.4 Price List (Interviewed) of Goserelin by Manufacturers

1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers

1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers

1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers

1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers

1.3.9 Price List (Interviewed) of Zytiga by Manufacturers

1.3.10 Price List (Interviewed) of Xtandi by Manufacturers

2 Competition Analysis by Manufacturers in Global and China

2.1 Global Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016

2.2 Global Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2015 to 2016

2.3 Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

2.4 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015

2.5 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015

2.6 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

3 Sales and Revenue Segments of Each Type 2010 to 2015

3.1 Global Sales and Revenue Segments of Each Type 2010 to 2015

3.1.1 Global Sales and Market Share of Each Type 2010 to 2015

3.1.2 Global Sales Growth Rate of Each Type 2015 to 2016

3.1.3 Global Revenue and Market Share of Each Type 2015 to 2016

3.1.4 Global Revenue and Market Share of Each Type 2015 to 2016

3.2 Global Sales and Revenue Segments of Each Type 2015 to 2016

3.2.1 Global Sales and Market Share of Each Type 2015 to 2016

3.2.2 Global Sales Growth Rate of Each Type 2015 to 2016

3.2.3 Global Revenue and Market Share of Each Type 2015 to 2016

3.2.4 Global Revenue and Market Share of Each Type 2015 to 2016

4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions

4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021

4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021

4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021

4.2 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021

4.2.1 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021

4.2.2 Production Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021

4.3 US Market Forecast to 2021

4.3.1 US Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021

4.4 Western Europe Market Forecast to 2021

4.4.1 Western Europe Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021

4.5 Emerging Markets Market Forecast to 2021

4.5.1 Emerging Markets Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021

4.6 Established ROW Market Forecast to 2021

4.6.1 Established ROW Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021

4.7 Russia Market Forecast to 2021

4.7.1 Russia Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021

4.8 China Market Forecast to 2021

4.8.1 China Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021

5 Raw Materials and Applications

5.1 Key Raw Materials and Price Analysis for Triptorelin

5.1.1 Key Raw Materials for Triptorelin

5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021

5.2 Key Raw Materials and Price Analysis for Leuprorelin

5.2.1 Key Raw Materials for Leuprorelin

5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021

5.3 Key Raw Materials and Price Analysis for Flutamide Tablets

5.3.1 Key Raw Materials for Flutamide Tablets

5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021

5.4 Key Raw Materials and Price Analysis for Goserelin

5.4.1 Key Raw Materials for Goserelin

5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021

5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets

5.5.1 Key Raw Materials for Bicalutamide Tablets

5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021

5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules

5.6.1 Key Raw Materials for Bicalutamide Capsules

5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021

5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules

5.7.1 Key Raw Materials for Estramustine Phosphate Capsules

5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021

5.8 Key Raw Materials and Price Analysis for Mitoxantrone

5.8.1 Key Raw Materials for Mitoxantrone

5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021

5.9 Key Raw Materials and Price Analysis for Zytiga

5.9.1 Key Raw Materials for Zytiga

5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021

5.10 Key Raw Materials and Price Analysis for Xtandi

5.10.1 Key Raw Materials for Xtandi

5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021

5.11 Applications of Triptorelin

5.12 Applications of Leuprorelin

5.13 Applications of Flutamide Tablets

5.14 Applications of Goserelin

5.15 Applications of Bicalutamide Tablets

5.16 Applications of Bicalutamide Capsules

5.17 Applications of Estramustine Phosphate Capsules

5.18 Applications of Mitoxantrone

5.19 Applications of Zytiga

5.20 Applications of Xtandi

6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer

6.1 IPSEN

6.1.1 IPSEN Basic Information

6.2.2 Triptorelin (Specification and Price)

6.2.3 Sales Value, Gross Margin 2011-2016

6.1.4 Interviewee, Name and Contact

6.2 Ferring Pharmaceuticals

6.2.1 Company Basic Information

6.2.2 Triptorelin (Specification and Price)

6.2.3 Sales Value, Gross Margin 2011-2016

6.2.4 Interviewee, Name and Contact

6.3 Chengdu Tiantaishan pharmaceutical

6.3.1 Company Basic Information

6.3.2 Triptorelin (Specification and Price)

6.3.3 Sales Value, Gross Margin 2011-2016

6.3.4 Interviewee, Name and Contact

6.4 GeneScience Pharmaceuticals

6.4.1 Company Basic Information

6.4.2 Triptorelin (Specification and Price)

6.4.3 Sales Value, Gross Margin 2011-2016

6.4.4 Interviewee, Name and Contact

6.5 Takeda Pharmaceutical Company Limited

6.5.1 Company Basic Information

6.5.2 Leuprorelin (Specification and Price)

6.5.3 Sales Value, Gross Margin 2011-2016

6.5.4 Interviewee, Name and Contact

6.6 Beijing Biote Pharmaceutical

6.6.1 Company Basic Information

6.6.2 Leuprorelin (Specification and Price)

6.6.3 Sales Value, Gross Margin 2011-2016

6.6.4 Interviewee, Name and Contact

6.7 Livzon Pharmaceutical Group

6.7.1 Company Basic Information

6.7.2 Leuprorelin (Specification and Price)

6.7.3 Sales Value, Gross Margin 2011-2016

6.7.4 Interviewee, Name and Contact

6.8 Schering-Plough Canada

6.8.1 Company Basic Information

6.8.2 Flutamide Tablets (Specification and Price)

6.8.3 Sales Value, Gross Margin 2011-2016

6.8.4 Interviewee, Name and Contact

6.9 JiangSu TASLY DI YI Pharmaceutical

6.9.1 Company Basic Information

6.9.2 Flutamide Tablets (Specification and Price)

6.9.3 Sales Value, Gross Margin 2011-2016

6.9.4 Interviewee, Name and Contact

6.10 Shanghai Fudan Fuhua Pharmaceutical

6.10.1 Company Basic Information

6.10.2 Flutamide Tablets (Specification and Price)

6.10.3 Sales Value, Gross Margin 2011-2016

6.10.4 Interviewee, Name and Contact

6.11 S.C.SINDAN-PHARMA S.R.L.

6.11.1 Company Basic Information

6.11.2 Flutamide Tablets (Specification and Price)

6.11.3 Sales Value, Gross Margin 2011-2016

6.11.4 Interviewee, Name and Contact

6.12 AstraZeneca

6.12.1 Company Basic Information

6.12.2 Goserelin (Specification and Price)

6.12.3 Sales Value, Gross Margin 2011-2016

6.12.4 Interviewee, Name and Contact

6.13 Corden Pharma GmbH

6.13.1 Company Basic Information

6.13.2 Bicalutamide Tablets (Specification and Price)

6.13.3 Sales Value, Gross Margin 2011-2016

6.13.4 Interviewee, Name and Contact

6.14 Shanghai Zhaohui Pharmaceutical

6.14.1 Company Basic Information

6.14.2 Bicalutamide Tablets (Specification and Price)

6.14.3 Sales Value, Gross Margin 2011-2016

6.14.4 Interviewee, Name and Contact

6.15 HISUN Pharmaceutical

6.15.1 Company Basic Information

6.15.2 Bicalutamide Tablets (Specification and Price)

6.15.3 Sales Value, Gross Margin 2011-2016

6.15.4 Interviewee, Name and Contact

6.16 Shanxi Zhendong Pharmaceutical

6.16.1 Company Basic Information

6.16.2 Bicalutamide Capsules (Specification and Price)

6.16.3 Sales Value, Gross Margin 2011-2016

6.16.4 Interviewee, Name and Contact

6.17 Pfizer

6.17.1 Company Basic Information

6.17.2 Estramustine Phosphate Capsules (Specification and Price)

6.17.3 Sales Value, Gross Margin 2011-2016

6.17.4 Interviewee, Name and Contact

6.18 Sichuan sunnyhope pharmaceutical

6.18.1 Company Basic Information

6.18.2 Mitoxantrone (Specification and Price)

6.18.3 Sales Value, Gross Margin 2011-2016

6.18.4 Interviewee, Name and Contact

6.19 Luoxin Group

6.19.1 Company Basic Information

6.19.2 Mitoxantrone (Specification and Price)

6.19.3 Sales Value, Gross Margin 2011-2016

6.19.4 Interviewee, Name and Contact

6.20 Jiangsu Aosaikang Pharmaceutical

6.20.1 Company Basic Information

6.20.2 Mitoxantrone (Specification and Price)

6.20.3 Sales Value, Gross Margin 2011-2016

6.20.4 Interviewee, Name and Contact

6.21 JIANG SU HENG RUI MEDICINE

6.21.1 Company Basic Information

6.21.2 Mitoxantrone (Specification and Price)

6.21.3 Sales Value, Gross Margin 2011-2016

6.21.4 Interviewee, Name and Contact

6.22 Johnson

6.22.1 Company Basic Information

6.22.2 Zytiga (Specification and Price)

6.22.3 Sales Value, Gross Margin 2011-2016

6.22.4 Interviewee, Name and Contact

6.23 Astellas

6.23.1 Company Basic Information

6.23.2 Xtandi (Specification and Price)

6.23.3 Sales Value, Gross Margin 2011-2016

6.23.4 Interviewee, Name and Contact

7 Technology Development Trend

7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer

7.2 Analysis of Manufacturing Process

7.3 Development Trend

8 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Drugs for Prostate Cancer 14

Figure Global Market Size (Value) of Drugs for Prostate Cancer 2016-2021 14

Figure Global Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 14

Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021 14

Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 15

Table Product Type of Key Manufacturers 15

Table Price List and Forecast of Each Type 15

Table Market Share of Each Type 15

Figure Growth Rate of Each Type 2015 to 2016 16

Figure Picture of Triptorelin 16

Table Specification of Triptorelin 16

Figure Picture of Leuprorelin 16

Table Specification of Leuprorelin 17

Figure Picture of Flutamide Tablets 17

Table Specification of Flutamide Tablets 17

Figure Picture of Goserelin 17

Table Specification of Goserelin 17

Figure Picture of Bicalutamide Tablets 17

Table Specification of Bicalutamide Tablets 17

Figure Picture of Type Bicalutamide Capsules 17

Table Specification of Type Bicalutamide Capsules 18

Figure Picture of Estramustine Phosphate Capsules 18

Table Specification of Estramustine Phosphate Capsules 18

Figure Picture of Mitoxantrone 18

Table Specification of Mitoxantrone 18

Figure Picture of Zytiga 18

Table Specification of Zytiga 18

Figure Picture of Xtandi 19

Table Specification of Xtandi 19

Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016 19

Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016 20

Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 20

Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 21

Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016 21

Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016 22

Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 22

Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 23

Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016 23

Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016 24

Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016 25

Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016 25

Table Global Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2015 to 2016 26

Table Global Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2015 to 2016 26

Table Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 27

Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 28

Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 28

Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 29

Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 29

Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 30

Table Global Sales of Each Type 2010 to 2015 31

Table Global Sales Market Share of Each Type 2010 to 2015 31

Table Global Sales Growth Rate of Each Type 2015 to 2016 31

Table Global Revenue of Each Type 2015 to 2016 32

Table Global Revenue Market Share of Each Type 2015 to 2016 32

Table Global Revenue of Each Type 2015 to 2016 32

Table Global Revenue Market Share of Each Type 2015 to 2016 33

Table China Sales of Each Type 2015 to 2016 33

Table China Sales Market Share of Each Type 2015 to 2016 33

Table Global Sales Growth Rate of Each Type 2015 to 2016 33

Table China Revenue of Each Type 2015 to 2016 34

Table China Revenue Market Share of Each Type 2015 to 2016 34

Table China Revenue of Each Type 2015 to 2016 34

Table China Revenue Market Share of Each Type 2015 to 2016 35

Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 36

Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 37

Table North America Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 2020 37

Table Europe Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 2020 38

Table Japan Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 38

Table India Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 39

Table Southeast Asia Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 39

Table China Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 40

Table Key Raw Materials for Triptorelin 41

Table Price Forecast of Key Raw Materials for Triptorelin 41

Table Key Raw Materials for Leuprorelin 42

Table Price Forecast of Key Raw Materials for Leuprorelin 42

Table Key Raw Materials for Flutamide Tablets 42

Table Price Forecast of Key Raw Materials for Flutamide Tablets 43

Table Key Raw Materials for Goserelin 43

Table Price Forecast of Key Raw Materials for Goserelin 43

Table Key Raw Materials for Bicalutamide Tablets 44

Table Price Forecast of Key Raw Materials for Bicalutamide Tablets 44

Table Key Raw Materials for Bicalutamide Capsules 45

Table Price Forecast of Key Raw Materials for Bicalutamide Capsules 45

Table Key Raw Materials for Estramustine Phosphate Capsules 45

Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 46

Table Key Raw Materials for Mitoxantrone 46

Table Price Forecast of Key Raw Materials for Mitoxantrone 47

Table Key Raw Materials for Zytiga 47

Table Price Forecast of Key Raw Materials for Zytiga 47

Table Key Raw Materials for Xtandi 48

Table Price Forecast of Key Raw Materials for Zytiga 48

Table Applications of Triptorelin 48

Table Applications of Leuprorelin 49

Table Applications of Flutamide Tablets 49

Table Applications of Goserelin 49

Table Applications of Bicalutamide Tablets 49

Table Applications of Bicalutamide Capsules 50

Table Applications of Estramustine Phosphate Capsules 50

Table Applications of Mitoxantrone 50

Table Applications of Zytiga 51

Table Applications of Xtandi 51

Table IPSEN Basic Information List 52

Table Specification, Price, Sales Value and Market Share of IPSEN 52

Table Sales Value, Gross Margin and Growth rate of IPSEN 52

Figure Product Sales Value, Growth rate of IPSEN 53

Table Ferring Pharmaceuticals Basic Information List 53

Table Specification, Price, Sales Value and Market Share of Ferring Pharmaceuticals 53

Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals 54

Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals 54

Table Chengdu Tiantaishan pharmaceutical Basic Information List 54

Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical 55

Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical 55

Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical 55

Table GeneScience Pharmaceuticals Basic Information List 55

Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals 56

Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals 56

Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals 56

Table Takeda Pharmaceutical Company Limited Basic Information List 57

Table Specification, Price, Sales Value and Market Share of Takeda Pharmaceutical Company Limited 57

Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited 57

Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited 58

Table Beijing Biote Pharmaceutical Basic Information List 58

Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical 58

Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical 59

Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical 59

Table Livzon Pharmaceutical Group Basic Information List 59

Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group 60

Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group 60

Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group 60

Table Schering-Plough Canada Basic Information List 60

Table Specification, Price, Sales Value and Market Share of Schering-Plough Canada 61

Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada 61

Figure Product Sales Value, Growth rate of Schering-Plough Canada 61

Table JiangSu TASLY DI YI Pharmaceutical Basic Information List 61

Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical 62

Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical 62

Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical 62

Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List 63

Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical 63

Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical 63

Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical 64

Table S.C.SINDAN-PHARMA S.R.L. Basic Information List 64

Table Specification, Price, Sales Value and Market Share of S.C.SINDAN-PHARMA S.R.L. 64

Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. 64

Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. 65

Table AstraZeneca Basic Information List 65

Table Specification, Price, Sales Value and Market Share of Pfizer 65

Table Sales Value, Gross Margin and Growth rate of AstraZeneca 66

Figure Product Sales Value, Growth rate of AstraZeneca 66

Table Corden Pharma GmbH Basic Information List 66

Table Specification, Price, Sales Value and Market Share of Corden Pharma GmbH 67

Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH 67

Figure Product Sales Value, Growth rate of Corden Pharma GmbH 67

Table Shanghai Zhaohui Pharmaceutical Basic Information List 67

Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical 68

Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical 68

Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical 68

Table HISUN Pharmaceutical Basic Information List 69

Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical 69

Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical 69

Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical 70

Table Shanxi Zhendong Pharmaceutical Basic Information List 70

Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical 70

Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical 70

Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical 71

Table Pfizer Basic Information List 71

Table Specification, Price, Sales Value and Market Share of Pfizer 71

Table Sales Value, Gross Margin and Growth rate of Pfizer 72

Figure Product Sales Value, Growth rate of Pfizer 72

Table Sichuan sunnyhope pharmaceutical Basic Information List 72

Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical 73

Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical 73

Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical 73

Table Luoxin Group Basic Information List 73

Table Specification, Price, Sales Value and Market Share of Luoxin Group 74

Table Sales Value, Gross Margin and Growth rate of Luoxin Group 74

Figure Product Sales Value, Growth rate of Luoxin Group 74

Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 75

Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical 75

Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical 75

Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical 76

Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 76

Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE 76

Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE 77

Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE 77

Table Johnson Basic Information List 77

Table Specification, Price, Sales Value and Market Share of Johnson 78

Table Sales Value, Gross Margin and Growth rate of Johnson 78

Figure Product Sales Value, Growth rate of Johnson 78

Table Astellas Basic Information List 78

Table Specification, Price, Sales Value and Market Share of Astellas 79

Table Sales Value, Gross Margin and Growth rate of Astellas 79

Figure Product Sales Value, Growth rate of Astellas 79

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370